_Logo%2520Page%2520daccueil%2520site_Logo%2520Page%2520daccueil%2520site.png){kind=logo}
HM
Hubert MECHAIN
Ilonov
Consultant expert CMC
Description
Hubert Méchain has a 20+ years’ experience of pharmaceutical development of innovative drug candidates. After a first experience as engineer for Sanofi-Synthelabo, he joined the GMP manufacturing site of Transgene (Mérieux group) specializing in immunotherapy. Hubert will spend almost 10 years leading this site, in charge of the manufacturing of hundreds of gene therapy clinical batches, for phase 1 to phase 3 studies, with international partners like Roche or Sanofi. Hubert then started a consulting activity in 2015 and, out of his different missions, had the opportunity to take charge of the transition management of Theravectys technical operations in 2016 and to join recently advisory board committees of ILONOV and SUPERBRANCHE.
Hubert finally joined BrainEver in late 2017 to oversee the biopharmaceutical activities as Chief Technical Officer.
Hubert holds a biological and applied microbiology engineering degree from the polytech Marseille Engineering University as well as a Master of Business Administration from EM Strasbourg Business school.
Loading